Compare PHAR & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PHAR | EQBK |
|---|---|---|
| Founded | 1988 | 2002 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 885.7M | 942.3M |
| IPO Year | 2020 | 2015 |
| Metric | PHAR | EQBK |
|---|---|---|
| Price | $12.87 | $47.19 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | $38.33 | ★ $51.33 |
| AVG Volume (30 Days) | 10.9K | ★ 64.8K |
| Earning Date | 05-07-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 1.59% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.80 |
| Revenue | N/A | N/A |
| Revenue This Year | $10.04 | $74.58 |
| Revenue Next Year | $2.51 | $5.11 |
| P/E Ratio | $3,041.22 | ★ $58.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.54 | $36.04 |
| 52 Week High | $21.34 | $50.07 |
| Indicator | PHAR | EQBK |
|---|---|---|
| Relative Strength Index (RSI) | 40.62 | 60.83 |
| Support Level | $11.84 | $44.38 |
| Resistance Level | $13.61 | $46.94 |
| Average True Range (ATR) | 0.41 | 0.90 |
| MACD | 0.08 | 0.09 |
| Stochastic Oscillator | 43.22 | 85.97 |
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 77 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.